Nuvectis Pharma's total assets for Q1 2026 were $25.40M, a decrease of -19.90% from the previous quarter. NVCT total liabilities were $11.18M for the fiscal quarter, a -15.93% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.